Citation Impact
Citing Papers
Recurrence rate after laparoscopic myomectomy
1998
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Differential Expression of the Angiogenic Factor Genes Vascular Endothelial Growth Factor (VEGF) and Endocrine Gland-Derived VEGF in Normal and Polycystic Human Ovaries
2003
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Corticotropin Releasing Hormone in the Pathophysiology of Melancholic and Atypical Depression and in the Mechanism of Action of Antidepressant Drugs
1995
Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study
2010
Inflammation and angiotensin II
2003
Mifepristone: Treatment of Cushing's Syndrome
1996
Obstetric outcome after in vitro fertilization with single or double embryo transfer
2010
Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995–2006
2010
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.
1998
Down-Regulation of Angiopoietin-1 Expression in Menorrhagia
2002
Infant outcome of 957 singletons born after frozen embryo replacement: The Danish National Cohort Study 1995–2006
2009
Endometriosis
2009 Standout
Cushing's syndrome
2015 Standout
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
PERIPHERAL ANTIGLUCOCORTICOID ACTION OF RU 486 IN MAN
1988
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Prostaglandin receptors are mediators of vascular function in endometrial pathologies
2006
Presence and Synthesis of Inhibin Subunits in Human Decidua*
1990
Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
1990 Standout
Identification of a cDNA Encoding a Long Form of Prolactin Receptor in Human Hepatoma and Breast Cancer Cells
1989
Selective Progesterone Receptor Modulators (SPRMs)
2002
Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries
1998
Angiogenesis in cancer and other diseases
2000 StandoutNature
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Oxidative stress and peritoneal endometriosis
2002
Angiogenesis in health and disease
2003 Standout
Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment
1998
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: A randomized controlled trial
1995
Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine
1997
Genomewide Linkage Study in 1,176 Affected Sister Pair Families Identifies a Significant Susceptibility Locus for Endometriosis on Chromosome 10q26
2005
Polycystic Ovary Syndrome
1995 Standout
Intragonadal Regulation of Follicular Maturation
1989
Uterine fibroids
2001 Standout
Fibroid-related Menorrhagia: Treatment with Superselective Embolization of the Uterine Arteries and Midterm Follow-up
2000
Heritability and molecular genetic studies of endometriosis
2000
A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception
2001
Molecular and biological properties of vascular endothelial growth factor
1999
Mifepristone (RU 486) in Cushing's syndrome
2007
Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis
2012 Standout
Interferons as Hormones of Pregnancy*
1992
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
1995
Endometriosis
2010 Standout
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
The search for genes contributing to endometriosis risk
2008
Factors affecting obstetric outcome of singletons born after IVF
2011
Interactions between activin and follicle-stimulating hormone-suppressing protein and their mechanisms of action on cultured rat granulosa cells
1991
Endometrial preparation: lessons from oocyte donation
1996
Biological properties of “naked” metal nanoparticles☆
2008
Clinical applications of angiogenic growth factors and their inhibitors
1999
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Endometriosis
2004 Standout
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Vascular endothelial growth factor is essential for corpus luteum angiogenesis
1998
Recurrent miscarriage
2006 Standout
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Laparoscopic myomectomy: indications, surgical technique and complications
1997
The Role of the Lymphatic System in Endometriosis: A Comprehensive Review of the Literature1
2015
Role of vascular endothelial growth factor in the regulation of angiogenesis
1999
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Time of Implantation of the Conceptus and Loss of Pregnancy
1999 Standout
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Mitigation of endometriosis using regenerative cerium oxide nanoparticles
2012
Angiogenesis as a therapeutic target
2005 StandoutNature
Long-term treatment of leiomyomas with gestrinone
1989
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
1998 Standout
The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome
1998
Successful Treatment of Cushing’s Syndrome with the Glucocorticoid Antagonist RU 486*
1985
Increased Adrenocorticotropin, Cortisol, and Arginine Vasopressin Secretion in Primates after the Antiglucocorticoid Steroid RU 486:Dose Response Relationships*
1985
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
2000 StandoutNobel
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
2000 StandoutNobel
Gonadotropin-releasing hormone, inhibin, and activin in human placenta: evidence for a common cellular localization.
1992
TGF-β SIGNAL TRANSDUCTION
1998 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
2000
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
2001
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Generation and reproductive phenotypes of mice lacking estrogen receptor β
1998 StandoutNobel
12 Common problems in induction of ovulation
1990
11 Frequency of implantation and early pregnancy loss in natural cycles
1991
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Localization and regulation of the activin-A dimer in human placental cells.
1992
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Abdominal myomectomy in the treatment of infertility
1993
Endometriosis
2020 Standout
Structural design and molecular evolution of a cytokine receptor superfamily.
1990 Standout
Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis
2002 StandoutNobel
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Glucocorticoid antagonists
1987
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Works of D. Healy being referenced
Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.
1984
Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation
1996
Angiongenesis: a new theory for endometriosis
1998
Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome
1994
Endocrinology and paracrinology: Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment
1995
Ovine trophoblast protein-1 and human interferon alpha reduce prostaglandin synthesis by ovine endometrial cells
1989
THE MATERNAL OVARY IS NOT THE SOURCE OF CIRCULATING INHIBIN LEVELS DURING HUMAN PREGNANCY
1987
Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia
2009
GnRH AGONIST ADMINISTRATION IN POLYCYSTIC OVARY SYNDROME
1989
Inhibin and ovarian cancer
1998
Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin‐releasing hormone agonist pretreated women
1994
Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection
2008
Uterine fibroids: A clinical review
1990
The role of GnRH agonists in the treatment of uterine fibroids
1992
Circulating Immunoreactive Inhibin Levels During the Normal Human Menstrual Cycle*
1987
A comparison of pregnancy rates for 131 donor oocyte transfers using either a sequential or fixed regime of steroid replacement therapy
1991
The human placenta: A novel source of inhibin
1986
PITUITARY AND ADRENAL RESPONSES TO THE ANTI-PROGESTERONE AND ANTI-GLUCOCORTICOID STEROID RU 486 IN PRIMATES1
1983
Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer.
1987
THE PRESENCE OF LACTOGEN RECEPTORS IN HUMAN CHORION LAEVE
1980